148 related articles for article (PubMed ID: 17907131)
1. Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists.
Spadoni G; Bedini A; Diamantini G; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Caronno A; Fraschini F
ChemMedChem; 2007 Dec; 2(12):1741-9. PubMed ID: 17907131
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
4. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
Rivara S; Lorenzi S; Mor M; Plazzi PV; Spadoni G; Bedini A; Tarzia G
J Med Chem; 2005 Jun; 48(12):4049-60. PubMed ID: 15943478
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines.
Tsotinis A; Eleutheriades A; Hough KA; Davidson K; Sugden D
Bioorg Chem; 2007 Apr; 35(2):189-204. PubMed ID: 17223160
[TBL] [Abstract][Full Text] [Related]
6. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
[TBL] [Abstract][Full Text] [Related]
7. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
[TBL] [Abstract][Full Text] [Related]
8. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
[TBL] [Abstract][Full Text] [Related]
9. Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives.
Bedini A; Lucarini S; Spadoni G; Tarzia G; Scaglione F; Dugnani S; Pannacci M; Lucini V; Carmi C; Pala D; Rivara S; Mor M
J Med Chem; 2011 Dec; 54(24):8362-72. PubMed ID: 22047556
[TBL] [Abstract][Full Text] [Related]
10. Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
Mésangeau C; Fraise M; Delagrange P; Caignard DH; Boutin JA; Berthelot P; Yous S
Eur J Med Chem; 2011 May; 46(5):1835-40. PubMed ID: 21392858
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
Attia MI; Witt-Enderby PA; Julius J
Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and melatoninergic activity of new unsubstituted and beta,beta'-difunctionalised 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-alkanamides.
Tsotinis A; Panoussopoulou M; Eleutheriades A; Davidson K; Sugden D
Eur J Med Chem; 2007 Jul; 42(7):1004-13. PubMed ID: 17346859
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
[TBL] [Abstract][Full Text] [Related]
16. Two conformers of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene spiro-linked with homobenzoquinone epoxide.
Asahara H; Koizumi T; Mochizuki E; Oshima T
Acta Crystallogr C; 2006 Mar; 62(Pt 3):o136-8. PubMed ID: 16518049
[TBL] [Abstract][Full Text] [Related]
17. Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands.
Spadoni G; Bedini A; Guidi T; Tarzia G; Lucini V; Pannacci M; Fraschini F
ChemMedChem; 2006 Oct; 1(10):1099-105. PubMed ID: 16955531
[TBL] [Abstract][Full Text] [Related]
18. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
[TBL] [Abstract][Full Text] [Related]
19. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
[TBL] [Abstract][Full Text] [Related]
20. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
Koike T; Hoashi Y; Takai T; Nakayama M; Yukuhiro N; Ishikawa T; Hirai K; Uchikawa O
J Med Chem; 2011 May; 54(9):3436-44. PubMed ID: 21473625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]